Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Clinical trial NCT06307652 · RECRUITING
Trial details
- NCT number
- NCT06307652
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-12
- Primary completion
- 2027-06-11
- Enrollment
- 4800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.